Eseng Lai

Antagonism of the prostaglandin D ₂ receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans

Kang Cheng, Tsuei-Ju Wu, Kenneth K. Wu et al. · Proceedings of the National Academy of Sciences · 2006 · 268 citations · Full text

Inflammation, Molecular Pharmacology, Signal Transduction +15

Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.

John F. Paolini, Yale Mitchel, Robert Reyes et al. · The American Journal of Cardiology · 2007 · 161 citations

Lipid Disorder, Study Investigators, Cardiovascular Disease +7

Effects of an 11 <i>β</i> ‐hydroxysteroid dehydrogenase type 1 inhibitor, MK‐0916, in patients with type 2 diabetes mellitus and metabolic syndrome

P. U. Feig, Sukrut Shah, Anne Hermanowski‐Vosatka et al. · Diabetes Obesity and Metabolism · 2011 · 157 citations

Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1

Eseng Lai, Inge De Lepeleire, TM Crumley et al. · Clinical Pharmacology & Therapeutics · 2007 · 149 citations

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin et al. · Human Vaccines & Immunotherapeutics · 2020 · 145 citations · Full text

Respiratory Virus Immunity, Viral Immunity, Immunology +19